Semi-specific immuno-absorption and monoclonal antibody therapy in ANCA positive vasculitis: experience in four cases.
The treatment of renal limited systemic vasculitis usually involves a combination of cytotoxic drugs and steroids. As shown by randomised prospective controlled trial, plasmapheresis may be of additional benefit for the management of patients with renal involvement severe enough to require dialysis...
Auteurs principaux: | Elliott, J, Lockwood, C, Hale, G, Waldmann, H |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
1998
|
Documents similaires
-
Monoclonal-antibody therapy in systemic vasculitis.
par: Mathieson, P, et autres
Publié: (1990) -
MONOCLONAL-ANTIBODY THERAPY IN SYSTEMIC VASCULITIS
par: Mathieson, P, et autres
Publié: (1990) -
HUMANIZED MONOCLONAL-ANTIBODY THERAPY FOR SYSTEMIC VASCULITIS
par: Lockwood, C, et autres
Publié: (1993) -
Long-term remission of intractable systemic vasculitis with monoclonal antibody therapy.
par: Lockwood, C, et autres
Publié: (1993) -
MONOCLONAL-ANTIBODIES IN SYSTEMIC VASCULITIS - LONG-TERM BENEFIT FROM SHORT-TERM THERAPY
par: Isaacs, J, et autres
Publié: (1993)